Differences in in vitro proliferative responsiveness to granulocyte colony-stimulating factor and interleukin 2 of bone marrow cells from mice treated with chemotherapeutic drugs.

The toxicity effects of several anticancer drugs on normal mouse bone marrow (BM) were estimated using the in vitro proliferative responsiveness [( 3H]thymidine incorporation) of the treated BM cells to recombinant human granulocyte colony-stimulating factor (G-CSF) and recombinant human interleukin 2 (IL-2). From the response pattern of the treated BM cells to G-CSF and IL-2, the anticancer drugs were classified into three groups: (a) BM cells from cyclophosphamide- or nimustine hydrochloride-treated mice showed an increased responsiveness to G-CSF but a decreased responsiveness to IL-2; (b) BM cells from vindesine- or peplomycin-treated mice showed an increased responsiveness to both G-CSF and IL-2; and (c) BM cells from mitomycin C-treated mice showed a decreased responsiveness to both G-CSF and IL-2. These different response patterns may reflect qualitative differences in the myelotoxicity effects of these anticancer drugs.

[1]  J. Gabrilove,et al.  Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium , 1989 .

[2]  J. Gutterman,et al.  Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, The New England journal of medicine.

[3]  J. Ihle,et al.  Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Crowther,et al.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. , 1987, British Journal of Cancer.

[5]  H. Nomura,et al.  Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice , 1987, Infection and immunity.

[6]  R. Neta,et al.  The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. , 1987, Journal of immunology.

[7]  C. Riccardi,et al.  Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors. , 1987, Journal of immunology.

[8]  M. F. Shannon,et al.  Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Sugimachi,et al.  Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. , 1987, Cancer research.

[10]  D. Williams,et al.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. , 1987, The Journal of clinical investigation.

[11]  S. Nagata,et al.  The chromosomal gene structure and two mRNAs for human granulocyte colony‐stimulating factor. , 1986, The EMBO journal.

[12]  V. Kindler,et al.  Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Rosenberg,et al.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2 , 1985, The Journal of experimental medicine.

[14]  S. Rosenberg,et al.  Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 , 1984, The Journal of experimental medicine.

[15]  W. Fried,et al.  EFFECT OF CYCLOPHOSPHAMIDE ON THE HEMATOPOIETIC MICROENVIRONMENTAL FACTORS WHICH INFLUENCE HEMATOPOIETIC STEM CELL PROLIFERATION , 1973, Cell and tissue kinetics.

[16]  P. Carbone,et al.  Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro. , 1971, Cancer research.

[17]  A. Goldin,et al.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity. , 1970, Cancer research.

[18]  S. Asano,et al.  Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. , 1989, Blood.

[19]  P. Quesenberry,et al.  Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. , 1988, Experimental hematology.